Other languages HitGen Inc.

Equities

688222

CNE1000040G3

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 27/06/2024 BST			5-day change	1st Jan Change
11.35 ^CNY	-0.09%		-4.22%	-24.28%

04-24	HitGen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
02-23	HitGen Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

HitGen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-24
HitGen Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02-23
HitGen Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23
The Structural Genomics Consortium and HitGen Inc. Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery	28/09/23
HitGen Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	22/08/23
HitGen Inc. Enters into DNA-Encoded Library Based Research Service Agreement with Nested Therapeutics, Inc	10/08/23
HitGen Inc. Launches A Newly Upgraded Version of OpenDELâ„¢, A Self-Service Screening Kit, to Facilitate Innovative Drug Discovery Research	26/06/23
HitGen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/04/23
HitGen Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	27/02/23
HitGen Inc. Announces Research Agreement with Nitrase Therapeutics, Inc. Focused on DNA-Encoded Library Based Drug Discovery	12/12/22
DAEWOONG PHARMACEUTICAL Co., Ltd and HitGen Inc. Announces Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery	14/11/22
HitGen Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	28/10/22
C4X Discovery Holdings plc and HitGen Inc. to Collaborate in Inflammation Hit Identification Project	20/10/22
HitGen Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	26/08/22
LoQus23 Therapeutics Ltd. and Hitgen Inc. Announces Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery	27/07/22
HitGen Inc. announces an Equity Buyback for CNY 30 million worth of its shares.	30/06/22
HitGen Inc. authorizes a Buyback Plan.	28/06/22
Almac Discovery Ltd and HitGen Inc. Announces Strategic Research Collaboration	20/05/22
HitGen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	28/04/22
HitGen Inc. and Uppthera Extend PROTAC Research Collaboration after Hit Finding Success on Undruggable Targets	06/04/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages HitGen Inc.

Equities

688222

CNE1000040G3

Other languages

Filters